Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model

Yubin Kang, Benny J. Chen, Divino DeOliveira et al. · 2010

Read Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model by Yubin Kang, Benny J. Chen, Divino DeOliveira et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011316.txt.

Description

Kang, Chen, DeOliveira and colleagues boosted transplants in mice for PLOS ONE in 2010. Donor blood stem cells must settle, or engraft, in a recipient's marrow for a transplant to work. A drug that blocks a homing receptor was given in a mouse transplant model to see if settling could be improved.

The drug selectively enhanced donor cell engraftment in their tests. Better settling could make transplants succeed with fewer donor cells, widening who can be treated. It might also speed recovery of blood counts after transplant. The finding informs bone marrow transplantation practice with a repurposed, already known drug.

Catalog record

CREATORYubin Kang, Benny J. Chen, Divino DeOliveira et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011316

Browse the full library · About the Tower of Babel